Table 2.
Cytokines | Localised type (n=26) | Sporadic type (n=24) | Generalised type (n=4) | P | ||
---|---|---|---|---|---|---|
| ||||||
Localised vs sporadic | Sporadic vs generalised | Localised vs generalised | ||||
CXCL9 (pg/ml) | 77.06+46.96 | 93.14+35.22 | 136.20+27.06 | 0.4562 | <0.05 | <0.05 |
CXCL10 (pg/ml) | 162.11+64.61 | 174.51+57.29 | 338.29+20.87 | 0.647 | <0.05 | <0.05 |
CXCL11 (pg/ml) | 124.76+61.13 | 150.10+77.72 | 307.91+56.33 | 0.446 | <0.05 | <0.05 |
A Student’s t-test was performed to compare the expression levels of CXCL9-11 among different types of vitiligo patients. A P<0.05 is considered significant